Directory
Xavier Matias-Guiu Guia

Xavier Matias-Guiu Guia

Degree: PhD

973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/C-3039-2009

Publications

  • Berek, JS; Matias-Guiu, X; Creutzberg, C; Fotopoulou, C; Gaffney, D; Kehoe, S; Lindemann, K; Mutch, D; Concin, N; Endometrial Canc Staging Subcomm; FIGO Womens Canc Comm

    FIGO staging of endometrial cancer: 2023

    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS 162 383-394. .

    [doi:10.1002/ijgo.14923]

  • Crosas-Molist E; Graziani V; Maiques O; Pandya P; Monger J; Samain R; George SL; Malik S; Salise J; Morales V; Le Guennec A; Atkinson RA; Marti RM; Matias-Guiu X; Charras G; Conte MR; Elosegui-Artola A; Holt M; Sanz-Moreno V

    AMPK is a mechano-metabolic sensor linking cell adhesion and mitochondrial dynamics to Myosin-dependent cell migration.

    Nature Communications 14 2740-2740. .

    [doi:10.1038/s41467-023-38292-0]

  • Lombaers MS; Cornel KMC; Visser NCM; Bulten J; Küsters-Vandevelde HVN; Amant F; Boll D; Bronsert P; Colas E; Geomini PMAJ; Gil-Moreno A; van Hamont D; Huvila J; Krakstad C; Kraayenbrink AA; Koskas M; Mancebo G; Matías-Guiu X; Ngo H; Pijlman BM; Vos MC; Weinberger V; Snijders MPLM; van Koeverden SW; Enitec-Consortium; Haldorsen IS; Reijnen C; Pijnenborg JMA

    Preoperative CA125 Significantly Improves Risk Stratification in High-Grade Endometrial Cancer.

    Cancers 15 -. .

    [doi:10.3390/cancers15092605]

  • Navaridas R; Vidal-Sabanés M; Ruiz-Mitjana A; Perramon-Güell A; Megino-Luque C; Llobet-Navas D; Matias-Guiu X; Egea J; Encinas M; Bardia L; Colombelli J; Dolcet X

    Transient and DNA-free in vivo CRISPR/Cas9 genome editing for flexible modeling of endometrial carcinogenesis.

    Cancer Communications 43 620-624. .

    [doi:10.1002/cac2.12409]

  • Jung-Garcia Y; Maiques O; Monger J; Rodriguez-Hernandez I; Fanshawe B; Domart MC; Renshaw MJ; Marti RM; Matias-Guiu X; Collinson LM; Sanz-Moreno V; Carlton JG

    LAP1 supports nuclear adaptability during constrained melanoma cell migration and invasion.

    NATURE CELL BIOLOGY 25 108-119. .

    [doi:10.1038/s41556-022-01042-3]

  • Devis-Jauregui L; Vidal A; Plata-Peña L; Santacana M; García-Mulero S; Bonifaci N; Noguera-Delgado E; Ruiz N; Gil M; Dorca E; Llobet FJ; Coll-Iglesias L; Gassner K; Martinez-Iniesta M; Rodriguez-Barrueco R; Barahona M; Marti L; Viñals F; Ponce J; Sanz-Pamplona R; Piulats JM; Vivancos A; Matias-Guiu X; Villanueva A; Llobet-Navas D

    Generation and Integrated Analysis of Advanced Patient-Derived Orthoxenograft Models (PDOX) for the Rational Assessment of Targeted Therapies in Endometrial Cancer.

    Advanced Science 10 -. .

    [doi:10.1002/advs.202204211]

  • Lopez-Mejia IC; Pijuan J; Navaridas R; Santacana M; Gatius S; Velasco A; Castellà G; Panosa A; Cabiscol E; Pinyol M; Coll L; Bonifaci N; Peña LP; Vidal A; Villanueva A; Gari E; Llobet-Navàs D; Fajas L; Matias-Guiu X; Yeramian A

    Oxidative stress-induced FAK activation contributes to uterine serous carcinoma aggressiveness.

    MOLECULAR ONCOLOGY 17 98-118. .

    [doi:10.1002/1878-0261.13346]

  • Tarragona J; Martínez-Ciarpaglini C; Matias-Guiu X; Hardisson D

    Docencia de pregrado en Anatomía Patológica: Resultados de la encuesta sobre la docencia de la asignatura de Anatomía Patológica en los estudios de pregrado de las facultades de medicina españolas.

    Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia 56 21-31. .

    [doi:10.1016/j.patol.2022.06.002]

  • Carton-Garcia, F; Brotons, B; Anguita, E; Dopeso, H; Tarragona, J; Nieto, R; Garcia-Vidal, E; Macaya, I; Zagyva, Z; Dalmau, M; Sanchez-Martin, M; van Ijzendoorn SCD; Landolfi, S; Hernandez-Losa, J; Schwartz S Jr; Matias-Guiu, X; Ramón Y Cajal S; Martinez-Barriocanal, A; Arango, D

    Myosin Vb as a tumor suppressor gene in intestinal cancer.

    ONCOGENE 41 5279-5288. .

    [doi:10.1038/s41388-022-02508-2]

  • Vrede SW; Kasius J; Bulten J; Teerenstra S; Huvila J; Colas E; Gil-Moreno A; Boll D; Vos MC; van Altena AM; Asberger J; Sweegers S; van Weelden WJ; van der Putten LJM; Amant F; Visser NCM; Snijders MPLM; Küsters-Vandevelde HVN; Kruitwagen R; Matias-Guiu X; Weinberger V; Reijnen C; Pijnenborg JMA

    Relevance of Molecular Profiling in Patients With Low-Grade Endometrial Cancer.

    JAMA Network Open 5 -. .

    [doi:10.1001/jamanetworkopen.2022.47372]

  • Palomero J; Panisello C; Lozano-Rabella M; Tirtakasuma R; Díaz-Gómez J; Grases D; Pasamar H; Arregui L; Dorca Duch E; Guerra Fernández E; Vivancos A; de Andrea CE; Melero I; Ponce J; Vidal A; Piulats JM; Matias-Guiu X; Gros A

    Biomarkers of tumor-reactive CD4(+) and CD8(+) TILs associate with improved prognosis in endometrial cancer.

    Journal for ImmunoTherapy of Cancer 10 -. .

    [doi:10.1136/jitc-2022-005443]

  • Sonzini, Giorgia; Granados-Aparici, Sofia; Sanegre, Sabina; Diaz-Lagares, Angel; Diaz-Martin, Juan; de Andrea, Carlos; Eritja, Nuria; Bao-Caamano, Aida; Costa-Fraga, Nicolas; Garcia-Ros, David; Salguero-Aranda, Carmen; Davidson, Ben; Lopez-Lopez, Rafael; Melero, Ignacio; Navarro, Samuel; Ramon Y Cajal, Santiago; de Alava, Enrique; Matias-Guiu, Xavier; Noguera, Rosa

    Integrating digital pathology with transcriptomic and epigenomic tools for predicting metastatic uterine tumor aggressiveness.

    Frontiers In Cell And Developmental Biology 10 1052098-1052098. .

    [doi:10.3389/fcell.2022.1052098]

Projects

  • Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
  • EPH Receptor Signaling in Endometrial Cancer
  • Ajuts per a la contractació de personal investigador novell (FI)
  • Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
  • "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
  • EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
  • Incorporación de nuevas areas temáticas y nuevos grupos al consorcio CIBER
  • Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
  • CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
  • DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
  • Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
  • VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU